Michael A. Heneghan
Division of Gastroenterology
Duke University Medical Center
Durham
NC 27710
USA
Name/email consistency: high
- De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant. Heneghan, M.A., Tuttle-Newhall, J.E., Suhocki, P.V., Muir, A.J., Morse, M., Bornstein, J.D., Sylvestre, P.B., Collins, B., Kuo, P.C., Rockey, D.C. Am. J. Transplant. (2003)
- Fulminant hepatic failure. Heneghan, M.A., Lara, L. Semin. Gastrointest. Dis. (2003)
- Current and novel immunosuppressive therapy for autoimmune hepatitis. Heneghan, M.A., McFarlane, I.G. Hepatology (2002)
- Cholestatic diseases of liver transplantation. Heneghan, M.A., Sylvestre, P.B. Semin. Gastrointest. Dis. (2001)
- Digestive disease week 2001. American association for the study of liver diseases. 19-23 May 2001, Atlanta, GA, USA. Heneghan, M.A. IDrugs (2001)